Lexicon Pharmaceuticals
LXRX
LXRX
137 hedge funds and large institutions have $1.41B invested in Lexicon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.4% less ownership
Funds ownership: 109.14% → 108.74% (-0.4%)
25% less capital invested
Capital invested by funds: $1.89B → $1.41B (-$478M)
88% less call options, than puts
Call options by funds: $1.77M | Put options by funds: $14.2M
Holders
137
Holding in Top 10
2
Calls
$1.77M
Puts
$14.2M
Top Buyers
| 1 | +$9.42M | |
| 2 | +$5.05M | |
| 3 | +$4.31M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.45M |
| 5 |
PA
Pinnacle Associates
New York
|
+$2.24M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$6.63M | |
| 3 | -$4.67M | |
| 4 |
Millennium Management
New York
|
-$3.8M |
| 5 |
CCI
Columbus Circle Investors
|
-$3.28M |